Ofatumumab vs Rituximab in Pemphigus Vulgaris: Real-World Data
A 13-author real-world cohort study comparing ofatumumab versus rituximab in pemphigus vulgaris appears in the JID October 2026 supplement (Vol. 146, Issue 10).
Topic
Ofatumumab
Topic
Topic
Topic
A 13-author real-world cohort study comparing ofatumumab versus rituximab in pemphigus vulgaris appears in the JID October 2026 supplement (Vol. 146, Issue 10).